E265 - Beyond Dopamine: Evolving Strategies for Antipsychotic Switching in Schizophrenia with Dr. Peter Weiden

In this episode, Dr. Andy Cutler interviews Dr. Peter Weiden about when and how to switch antipsychotics in schizophrenia, tackling both the pitfalls and opportunities clinicians face in practice. They also explore how xanomeline – trospium has opened the door to treatments beyond dopamine and what this shift means for the future of care. Peter J. Weiden, MD, is a psychiatrist and internationally recognized expert in the pharmacologic treatment of schizophrenia. His research and clinical work have focused on antipsychotic effectiveness, switching strategies, and medication adherence, with a particular emphasis on optimizing long-term outcomes for patients. Andrew J. Cutler, MD , is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and holds the position of Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York . Never miss an episode! 🎙

You can listen to E265 - Beyond Dopamine: Evolving Strategies for Antipsychotic Switching in Schizophrenia with Dr. Peter Weiden online on Radio and Podcast. Open the player on this page to stream the available audio.

E265 - Beyond Dopamine: Evolving Strategies for Antipsychotic Switching in Schizophrenia with Dr. Peter Weiden is an episode from NEI Podcast by Neuroscience Education Institute.

This episode is 57:39 long.

This episode was published on Oct 8, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from NEI Podcast when more episodes are available from the podcast feed.